Rare diseases
Investigational molecules
Locations
Calle De San Agustin 9, 46980, Spain
Arthex Biotech S.L. is focused on clinical research in myotonic dystrophy type 1 (DM1), a hereditary neuromuscular disorder associated with progressive muscle weakness and multisystem involvement.
The sponsor’s research activity is centered on adult participants with DM1, reflecting a therapeutic interest in inherited conditions affecting muscle function and motor performance.
Arthex Biotech S.L. runs clinical trials in conditions such as Myotonic dystrophy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
